Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China flag China · Delayed Price · Currency is CNY
9.81
-0.15 (-1.51%)
At close: Feb 13, 2026

SHE:300009 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Operating Revenue
2,5752,5332,8612,3272,1601,694
Other Revenue
2.652.654.574.188.57.69
2,5772,5362,8662,3312,1691,701
Revenue Growth (YoY)
-6.81%-11.51%22.94%7.48%27.47%-0.65%
Cost of Revenue
625.15581.16626.15513.47436.15364.09
Gross Profit
1,9521,9552,2401,8181,7331,337
Selling, General & Admin
999.3986.631,035871.18942.68791.65
Research & Development
218.1201.29254.68166.01166.54128.76
Other Operating Expenses
5.210.3217.2119.3219.4716.38
Operating Expenses
1,2351,1951,3271,0621,133940.64
Operating Income
716.86759.46912.92755.7599.3396.69
Interest Expense
-1.99-2.4-1.87-1.52-1.62-1.62
Interest & Investment Income
15.3620.425.899.6111.5213.6
Currency Exchange Gain (Loss)
0.080.080.860.063.92-0.07
Other Non Operating Income (Expenses)
-5.77-2.79-1.1126.47-12.29-16.26
EBT Excluding Unusual Items
724.54774.76916.69790.32600.83392.35
Impairment of Goodwill
-----322.6-
Gain (Loss) on Sale of Investments
14.8610.52-15.4419.86-2.24-15.42
Gain (Loss) on Sale of Assets
0.841.090.12-1.21.68-0.02
Asset Writedown
-3.61-0.15-1.49-4.47-0.84-0.03
Other Unusual Items
16.816.820.0529.3418.2839.27
Pretax Income
753.43803.02919.93833.85295.12416.14
Income Tax Expense
74.8887.1861.3496.1991.7369.6
Earnings From Continuing Operations
678.54715.84858.59737.66203.39346.53
Minority Interest in Earnings
-9.83-8.89-11.36-34.43.2412.42
Net Income
668.71706.95847.23703.26206.63358.96
Net Income to Common
668.71706.95847.23703.26206.63358.96
Net Income Growth
-14.54%-16.56%20.47%240.35%-42.44%188.40%
Shares Outstanding (Basic)
1,6651,6741,6741,6351,5891,632
Shares Outstanding (Diluted)
1,6651,6741,6741,6351,5891,632
Shares Change (YoY)
-0.84%0.02%2.34%2.90%-2.58%-1.68%
EPS (Basic)
0.400.420.510.430.130.22
EPS (Diluted)
0.400.420.510.430.130.22
EPS Growth
-13.83%-16.57%17.72%230.77%-40.91%193.33%
Free Cash Flow
748.51568.15757.64224.64460.94326.27
Free Cash Flow Per Share
0.450.340.450.140.290.20
Dividend Per Share
0.1500.2500.2500.2500.2000.167
Dividend Growth
-57.14%--25.00%19.98%73.28%
Gross Margin
75.74%77.08%78.15%77.97%79.89%78.60%
Operating Margin
27.81%29.95%31.86%32.42%27.63%23.32%
Profit Margin
25.95%27.88%29.56%30.17%9.53%21.10%
Free Cash Flow Margin
29.04%22.40%26.44%9.64%21.25%19.18%
EBITDA
808.04846.07993.44836.21676.71462.67
EBITDA Margin
31.35%33.36%34.67%35.87%31.20%27.19%
D&A For EBITDA
91.1886.6180.5280.577.4165.99
EBIT
716.86759.46912.92755.7599.3396.69
EBIT Margin
27.81%29.95%31.86%32.42%27.63%23.32%
Effective Tax Rate
9.94%10.86%6.67%11.54%31.08%16.73%
Revenue as Reported
2,5772,5362,8662,3312,1691,701
Advertising Expenses
-33.4411.128.249.966
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.